Since ERβ2 has a suggested oncogenic role in prostate cancer, and its splice variant ERβ1 is a tumor suppressor known to inhibit HIF-1α, we here investigated whether ERβ2 can increase HIF-1α stabilization, and whether this mechanism underlies the correlation of both factors with aggressive, metastasizing, prostate cancer. Here, HIF1A is linked to neoplasm.